Brexit from the inside: MP’s views on how it will impact pharmaWith the potential for a hard-no-deal Brexit becoming closer to reality with each passing day, the question of Share XBrexit from the inside: MP’s views on how it will impact pharmahttps://pharmaphorum.com/views-and-analysis/brexit-inside-mps-views-impact-pharma/
Boehringer joins UK academics in battle against cystic fibrosisBoehringer Ingelheim (BI) and the UK Cystic Fibrosis Gene Therapy Consortium announced a global collaboration to develop a Share XBoehringer joins UK academics in battle against cystic fibrosishttps://pharmaphorum.com/news/boehringer-battles-against-cystic-fibrosis/
NHS faces legal action over fertility treatment for gender transitioning patientsEngland’s NHS must offer transgender patients awaiting transitioning treatment access to fertility services, or face legal action according Share XNHS faces legal action over fertility treatment for gender transitioning patientshttps://pharmaphorum.com/news/nhs-fertility-treatment-gender-transitioning-patients/
EMA cuts services amid Brexit staff exodusEurope’s medicines regulator has said it is temporarily cutting services as it will lose at least 30% of Share XEMA cuts services amid Brexit staff exodushttps://pharmaphorum.com/news/ema-cuts-services-amid-brexit-staff-exodus/
Neurofibromatosis treatment granted orphan status by EMAAstraZeneca and Merck & Co. announced the European Medicines Agency (EMA) has granted orphan designation to their codeveloped Share XNeurofibromatosis treatment granted orphan status by EMAhttps://pharmaphorum.com/news/nf1-treatment-granted-orphan-status-ema/
New Huntington’s drug granted priority designationRoche’s treatment for Huntington’s disease has received a priority designation by the European regulator, sparking hope that a Share XNew Huntington’s drug granted priority designationhttps://pharmaphorum.com/news/huntingtons-drug-granted-priority-designation/
Sanofi stockpiles drugs in case of no-deal BrexitFears of border delays and complications in a post-Brexit UK have led to the French pharmaceutical company increasing Share XSanofi stockpiles drugs in case of no-deal Brexithttps://pharmaphorum.com/news/sanofi-stockpiles-drugs-case-deal-brexit/
Breakthrough migraine prevention treatment approved in EuropeNovartis’ Aimovig (erenumab) has been approved by the European Medicines Agency (EMA) making it first self-administered, monthly migraine Share XBreakthrough migraine prevention treatment approved in Europehttps://pharmaphorum.com/news/breakthrough-migraine-prevention-treatment-approved-in-europe/
Vertex and Alnylam orphan drugs set for EU approvalOrphan drugs for cystic fibrosis and the hereditary rare disease hATTR are on course for European approval after Share XVertex and Alnylam orphan drugs set for EU approvalhttps://pharmaphorum.com/market-access-2/chmp-vertex-symkevi-alnylam-onpattro/
